References
- Neuhauser HK. Epidemiology of vertigo. Curr Opin Neurol 2007; 20: 40–6
- Brandt T, Dieterich M, Strupp M. Vertigo and dizziness – common complaints. Springer, London 2005
- Merchant SN, Adams JC, Nadol JB, Jr. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops?. Otol Neurotol 2005; 26: 74–81
- Minor LB, Schessel DA, Carey JP. Meniere's disease. Curr Opin Neurol 2004; 17: 9–16
- Yeh TH, Herman P, Tsai MC, Tran-Ba-Huy P, Van-den-Abbeele T. A cationic nonselective stretch-activated channel in the Reissner's membrane of the guinea pig cochlea. Am J Physiol 1998; 274(3 Pt 1)C566–C576
- James A, Thorp M. Meniere's disease. Clin Evid 2005;(14):659–65.
- Strupp M, Brandt T. Pharmacological advances in the treatment of neuro-otological and eye movement disorders. Curr Opin Neurol 2006; 19: 33–40
- Smith WK, Sankar V, Pfleiderer AG. A national survey amongst UK otolaryngologists regarding the treatment of Meniere's disease. J Laryngol Otol 2005; 119: 102–5
- James AL, Burton MJ. Betahistine for Menière's disease or syndrome. The Cochrane Database of Systematic Reviews 2001; CD001873(1).
- Strupp M, Cnyrim C, Brandt T. Vertigo and dizziness: treatment of benign paroxysmal positioning vertigo, vestibular neuritis and Menère's disease. Evidence-based neurology – management of neurological disorders, L Candelise. Blackwell Publishing, Oxford 2007; 59–69
- Best C, Eckhardt-Henn A, Diener G, Bense S, Breuer P, Dieterich M. Interaction of somatoform and vestibular disorders. J Neurol Neurosurg Psychiatry 2006; 77: 658–64
- van Cruijsen N., Jaspers JP, van de Wiel HB, Wit HP, Albers FW. Psychological assessment of patients with Meniere's disease. Int J Audiol 2006; 45: 496–502
- Elia JC. Double-blind evaluation of a new treatment for Meniere's syndrome. JAMA 1966; 196: 187–9
- Schmidt JT, Huizing EH. The clinical drug trial in Meniere's disease with emphasis on the effect of betahistine SR. Acta Otolaryngol Suppl 1992; 497: 18–19
- Dziadziola JK, Laurikainen EL, Rachel JD, Quirk WS. Betahistine increases vestibular blood flow. Otolaryngol Head Neck Surg 1999; 120: 400–5
- Lamm K, Arnold W. The effect of blood flow promoting drugs on cochlear blood flow, perilymphatic pO(2) and auditory function in the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Hear Res 2000; 141: 199–219
- Laurikainen E, Miller JF, Pyykko I. Betahistine effects on cochlear blood flow: from the laboratory to the clinic. Acta Otolaryngol Suppl 2000; 544: 5–7
- Jeck-Thole S, Wagner W. Betahistine: a retrospective synopsis of safety data. Drug Saf 2006; 29: 1049–59
- Green JD, Jr, Blum DJ, Harner SG. Longitudinal followup of patients with Meniere's disease. Otolaryngol Head Neck Surg 1991; 104: 783–8
- Hamill TA. Evaluating treatments for Meniere's disease: controversies surrounding placebo control. J Am Acad Audiol 2006; 17: 27–37